Efficacy and safety of biological agents for systemic juvenile idiopathic arthritis: a systematic review and meta-analysis of randomized trials

2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among C

(2015) Sarah Ringold et al.   ARTHRITIS AND RHEUMATISM

Update on research and clinical translation on specific clinical areas: From bench to bedside: How insight in immune pathogenesis can lead to precision medicine of severe juvenile idiopathic arthritis

(2014) Sebastiaan Vastert et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis

(2014) Norman T. Ilowite et al.   Arthritis & Rheumatology

Impact of the European paediatric legislation in paediatric rheumatology: past, present and future: Table 1

(2013) Nicolino Ruperto et al.   ANNALS OF THE RHEUMATIC DISEASES

Long-Term Safety and Efficacy of Rilonacept in Patients With Systemic Juvenile Idiopathic Arthritis

(2013) Daniel J. Lovell et al.   ARTHRITIS AND RHEUMATISM

Demystifying trial networks and network meta-analysis

(2013) E. J. Mills et al.   BMJ-British Medical Journal

Efficacy of biological agents in juvenile idiopathic arthritis: a systematic review using indirect comparisons

(2012) Marieke H Otten et al.   ANNALS OF THE RHEUMATIC DISEASES

Systemic juvenile idiopathic arthritis

(2012) Alberto Martini   AUTOIMMUNITY REVIEWS

How to Use an Article Reporting a Multiple Treatment Comparison Meta-analysis

(2012) Edward J. Mills et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

GRADE guidelines: 12. Preparing Summary of Findings tables—binary outcomes

(2012) Gordon H. Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis

(2012) Nicolino Ruperto et al.   NEW ENGLAND JOURNAL OF MEDICINE

Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis

(2012) Fabrizio De Benedetti et al.   NEW ENGLAND JOURNAL OF MEDICINE

GRADE guidelines: 3. Rating the quality of evidence

(2011) Howard Balshem et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables

(2011) Gordon Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Indirect and mixed treatment comparisons in arthritis research

(2011) A. E. Ades et al.   RHEUMATOLOGY

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features

(2011) Timothy Beukelman et al.   ARTHRITIS CARE & RESEARCH

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

(2010) P. Quartier et al.   ANNALS OF THE RHEUMATIC DISEASES

Is it time to move to active comparator trials in juvenile idiopathic arthritis?: A review of current study designs

(2010) Nicolino Ruperto et al.   ARTHRITIS AND RHEUMATISM

A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview

(2009) J. A. Singh et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

(2009) Alessandro Liberati et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

(2008) Shumpei Yokota et al.   LANCET